The UK is facing mounting pressure from the United States to reform its drug pricing policies, with the US ambassador, Warren Stephens, delivering a stark ultimatum to government officials and
All posts tagged in NHS2- Page
56Articles
Prostate cancer screening for men over 50 could transform outcomes in Britain, according to one of the largest trials ever conducted in Europe. The latest data from the European Randomised
The landscape of prostate cancer diagnosis is on the cusp of transformation as the NHS introduces rapid new trials deploying artificial intelligence. Men presenting with possible symptoms of prostate cancer
Latest figures reveal a dramatic increase in the number of Britons opting for medical treatment abroad, spurred by mounting NHS waiting lists and ongoing concerns about accessibility within the UK
The National Health Service is poised for what health chiefs are describing as a radical reset, prioritising a digital-first approach to urgent and emergency care. As part of a three-year
AstraZeneca has announced a major shift in its transatlantic pricing strategy, pledging to sharply reduce the cost of its medicines in the United States following mounting political pressure. The pharmaceutical
Weight loss injections have rapidly transformed the British approach to tackling obesity, with an extraordinary surge in private usage. Latest data suggests that 2.5 million adults in the UK—one in
Senior doctors are warning that the NHS is in a state of emergency despite Chancellor Rachel Reeves injecting an additional £25 billion into the health service this year. Labour has
Sir Keir Starmer is preparing to overhaul NHS value for money protocols in a high-stakes move that could see Britain pour billions more into pharmaceutical spending. This comes amid escalating
The UK pharmaceutical sector, long celebrated as a linchpin of the British economy, now faces an unprecedented crisis following the imposition of sweeping new tariffs by Donald Trump. In a
Moderna has marked a significant milestone in the UK pharmaceuticals landscape by launching a £150m manufacturing and research facility in Oxfordshire. The ribbon-cutting ceremony, attended by Moderna’s chief executive Stéphane
NHS staff outperformed government expectations last year, delivering a sharp improvement in productivity and offering a timely win for Chancellor Rachel Reeves ahead of the crucial autumn Budget. For the
Recent public announcements of cancer diagnoses by high-profile figures have inadvertently contributed to significant delays in the National Health Service’s cancer referral process, a senior coroner has observed. Samantha Goward,
Bristol Myers Squibb BMS has issued a pointed demand for the NHS to fund a greater share of pharmaceutical innovation calling for the UK to pay what it describes as
Britain’s pharmaceutical sector has been thrust into sharp focus as the government pledges urgent action to resolve a standoff with multinational drug companies. In the aftermath of several high-profile withdrawals
The United Kingdom is facing a stark decline in its attractiveness to global investors in the life sciences and pharmaceutical industries, with industry leaders warning the nation is falling behind
